Chao, Ting-Ting <br/><br/>
TD-19, an erlotinib derivative, induces epidermal growth factor receptor wild-type nonsmall-cell lung cancer apoptosis through CIP2A-mediated pathway.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Nov 2014 
 - 352-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.114.215418  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Autoantigens--metabolism<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Caspase 3--metabolism<br/>Caspase 9--metabolism<br/>Cell Line, Tumor<br/>Down-Regulation--drug effects<br/>ErbB Receptors--metabolism<br/>Erlotinib Hydrochloride<br/>Humans<br/>Intracellular Signaling Peptides and Proteins<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Membrane Proteins--metabolism<br/>Mice<br/>Mice, Nude<br/>Phosphorylation--drug effects<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Protein Phosphatase 2--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Quinazolines--pharmacology